BERTAGNIN, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.262
AS - Asia 852
EU - Europa 507
SA - Sud America 217
AF - Africa 169
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 3.025
Nazione #
US - Stati Uniti d'America 1.160
SG - Singapore 319
CN - Cina 205
BR - Brasile 139
IT - Italia 87
DE - Germania 69
VN - Vietnam 58
HK - Hong Kong 57
NL - Olanda 42
FI - Finlandia 31
KR - Corea 31
RU - Federazione Russa 28
FR - Francia 24
PL - Polonia 22
GB - Regno Unito 18
AR - Argentina 16
IE - Irlanda 16
IN - India 16
MX - Messico 16
CA - Canada 15
SE - Svezia 15
EC - Ecuador 14
UA - Ucraina 14
ID - Indonesia 13
JP - Giappone 13
AT - Austria 12
BA - Bosnia-Erzegovina 11
TR - Turchia 11
PY - Paraguay 10
UY - Uruguay 10
CI - Costa d'Avorio 9
ES - Italia 9
PT - Portogallo 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
DK - Danimarca 8
IQ - Iraq 8
JO - Giordania 8
ZA - Sudafrica 8
BE - Belgio 7
CL - Cile 7
GR - Grecia 7
LB - Libano 7
LY - Libia 7
MN - Mongolia 7
PA - Panama 7
AO - Angola 6
BB - Barbados 6
CD - Congo 6
CZ - Repubblica Ceca 6
EE - Estonia 6
GA - Gabon 6
GF - Guiana Francese 6
GH - Ghana 6
HR - Croazia 6
IR - Iran 6
JM - Giamaica 6
KG - Kirghizistan 6
MR - Mauritania 6
MZ - Mozambico 6
NC - Nuova Caledonia 6
RS - Serbia 6
SO - Somalia 6
YT - Mayotte 6
BF - Burkina Faso 5
CG - Congo 5
CH - Svizzera 5
CM - Camerun 5
CO - Colombia 5
CR - Costa Rica 5
CV - Capo Verde 5
DJ - Gibuti 5
GP - Guadalupe 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
MD - Moldavia 5
MU - Mauritius 5
MW - Malawi 5
MY - Malesia 5
PH - Filippine 5
PR - Porto Rico 5
RE - Reunion 5
SI - Slovenia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
ZW - Zimbabwe 5
AE - Emirati Arabi Uniti 4
AF - Afghanistan, Repubblica islamica di 4
AL - Albania 4
BD - Bangladesh 4
BJ - Benin 4
BO - Bolivia 4
BZ - Belize 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GT - Guatemala 4
IS - Islanda 4
KE - Kenya 4
Totale 2.892
Città #
Ashburn 222
Singapore 156
Fairfield 116
Chandler 79
Beijing 60
Hong Kong 55
Woodbridge 52
Seattle 47
Cambridge 46
Houston 44
Santa Clara 35
Ann Arbor 32
Hefei 30
Wilmington 27
Seoul 26
Columbus 24
Munich 23
Boardman 22
Ho Chi Minh City 22
Los Angeles 22
San Diego 20
San Jose 20
Council Bluffs 18
Helsinki 18
Bytom 17
New York 17
Dublin 16
Frankfurt am Main 15
Padova 15
Medford 11
Milan 11
Princeton 11
São Paulo 11
Buffalo 10
Montevideo 10
Roxbury 9
Abidjan 8
Amman 8
Des Moines 8
Guangzhou 8
Montreal 8
Rome 8
San Donà di Piave 8
Tokyo 8
Baku 7
Berlin 7
Panama City 7
Stockholm 7
The Dalles 7
Turku 7
Ulan Bator 7
Accra 6
Bridgetown 6
Chennai 6
Denver 6
Hanoi 6
Kyiv 6
Noumea 6
Nuremberg 6
Orem 6
Shanghai 6
Tripoli 6
Washington 6
Bishkek 5
Brooklyn 5
Chicago 5
Fossò 5
Guayaquil 5
Haiphong 5
Harare 5
Johannesburg 5
Kampong Loyang 5
Lappeenranta 5
Libreville 5
London 5
Luanda 5
Maputo 5
Nouakchott 5
Asunción 4
Biên Hòa 4
Boston 4
Cayenne 4
Chisinau 4
Dakar 4
Kinshasa 4
Lilongwe 4
Ouagadougou 4
Poplar 4
Port of Spain 4
Praia 4
Quito 4
Ribeirão Preto 4
San José 4
Sarajevo 4
Vienna 4
Vientiane 4
Willemstad 4
Yekaterinburg 4
Americana 3
Amsterdam 3
Totale 1.715
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 273
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 233
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 214
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 209
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant 195
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 183
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant 178
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 161
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 160
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 150
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity 140
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant 132
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties 129
Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability 123
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 105
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 100
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 98
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles 97
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 97
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation 91
Totale 3.068
Categoria #
all - tutte 9.931
article - articoli 9.931
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 1 9 28 5 33 33
2021/2022201 4 9 20 26 17 17 11 21 3 12 24 37
2022/2023198 28 17 8 16 29 39 0 12 19 12 11 7
2023/2024202 2 16 41 11 26 21 29 21 2 11 7 15
2024/2025630 1 31 43 26 56 42 36 63 44 19 83 186
2025/20261.496 191 248 305 347 225 138 42 0 0 0 0 0
Totale 3.068